Guided Therapeutics, Inc.

Guided Therapeutics, Inc. - ROEverified

GTHP

Price:

$0.29

Market Cap:

$22.24M

Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.

Industry

Medical - Devices

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

GTHP

The ROE as of June 2026 (TTM) for Guided Therapeutics, Inc. (GTHP) is 70.53%

According to Guided Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 70.53%. This represents a change of 301.43% compared to the average of 17.57% of the last 4 quarters.

Guided Therapeutics, Inc. (GTHP) Historical ROE (quarterly & annually)

How has GTHP ROE performed in the past?

The mean historical ROE of Guided Therapeutics, Inc. over the last ten years is 48.84%. The current 70.53% ROE has changed 44.42% with respect to the historical average. Over the past ten years (40 quarters), GTHP's ROE was at its highest in in the December 2022 quarter at 62.68%. The ROE was at its lowest in in the March 2025 quarter at -49.02%.

Quarterly (TTM)
Annual

Average

48.84%

Median

46.14%

Minimum

-6.42%

Maximum

150.57%

Guided Therapeutics, Inc. (GTHP) ROE by Quarter and Year

Discovering the peaks and valleys of Guided Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.38%

Maximum Annual ROE = 150.57%

Minimum Annual Increase = -276.67%

Minimum Annual ROE = -6.42%

Quarterly (TTM)
Annual
YearROEChange
202553.21%7.64%
202449.44%-46.07%
202391.67%-39.12%
2022150.57%296.07%
202138.02%1.38%
20202.57%-77.34%
201911.34%-276.67%
2018-6.42%-111.65%
201755.13%28.67%
201642.84%-65.47%

Guided Therapeutics, Inc. (GTHP) Average ROE

How has GTHP ROE performed in the past?

The current ROE of Guided Therapeutics, Inc. (GTHP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

64.77%

5-year avg

76.58%

10-year avg

48.84%

Guided Therapeutics, Inc. (GTHP) ROE vs. Peers

How is GTHP’s ROE compared to its peers?

Guided Therapeutics, Inc.’s ROE is less than Biotricity, Inc. (12.85%), greater than Aurora Spine Corporation (-15.61%), greater than Perimeter Medical Imaging AI, Inc. (-300.64%), less than CareView Communications, Inc. (7.12%), greater than Elbit Imaging Ltd. (-8.13%), less than United Health Products, Inc. (39.88%), less than AccuStem Sciences Limited (55.23%), less than VentriPoint Diagnostics Ltd. (78.25%), greater than Immunovia AB (publ) (-353.07%), greater than Zenith Capital Corp. (0%),

Build a custom stock screener for Guided Therapeutics, Inc. (GTHP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guided Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guided Therapeutics, Inc. (GTHP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guided Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Guided Therapeutics, Inc.'s ROE?

How is the ROE calculated for Guided Therapeutics, Inc. (GTHP)?

What is the highest ROE for Guided Therapeutics, Inc. (GTHP)?

What is the 3-year average ROE for Guided Therapeutics, Inc. (GTHP)?

What is the 5-year average ROE for Guided Therapeutics, Inc. (GTHP)?

How does the current ROE for Guided Therapeutics, Inc. (GTHP) compare to its historical average?